MarketCap
Arcturus Therapeutics Holdings ARCT
€ 9.20
1.35%
Facebook
X
Telegram
Land |
 Israel |
IPO-Jahr |
2013 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
27.4 M |
Marktkapitalisierung |
$ 283 M |
EBITDA (LTM) |
$ -73.2 M |
P/E (LTM) |
-6.591667 |
P/S (LTM) |
5.281497 |
EPS (LTM) |
-2.4 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB |  USA |
 |
argenx SE
ARGX
|
$ 819.14 | 3.42 % | $ 50.2 B | Nasdaq Global Select Market |  Niderland |
 |
89bio
ETNB
|
- | - | $ 1.55 B | Nasdaq Global Market | USA |
 |
Bristol-Myers Squibb Company
BMY
|
$ 59.75 | 0.12 % | $ 122 B | NYSE,SPB | USA |
 |
Nkarta
NKTX
|
$ 1.8 | 1.35 % | $ 133 M | Nasdaq Global Select Market | USA |
 |
Cabaletta Bio
CABA
|
$ 1.41 | 0.5 % | $ 142 M | Nasdaq Global Select Market | USA |
 |
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market |  Canada |
 |
CytomX Therapeutics
CTMX
|
$ 2.28 | 8.07 % | $ 314 M | Nasdaq Global Select Market | USA |
 |
Mirati Therapeutics
MRTX
|
- | - | $ 3.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Novavax
NVAX
|
$ 11.26 | 1.42 % | $ 1.82 B | Nasdaq Global Select Market | USA |
 |
Novo Nordisk A/S
NVO
|
$ 38.83 | 0.14 % | $ 173 B | NYSE |  Danmark |
 |
Novartis AG
NVS
|
$ 150.62 | 0.16 % | $ 292 B | NYSE |  Schweiz |
 |
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 9.18 | 2.64 % | $ 115 M | Nasdaq Global Select Market,SPB | USA |
 |
Ocular Therapeutix
OCUL
|
$ 6.87 | 2.5 % | $ 1.29 B | Nasdaq Global Select Market | USA |
 |
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 6.58 | 1.03 % | $ 572 M | Nasdaq Global Select Market | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 16.51 | 0.72 % | $ 2.22 B | Nasdaq Global Market | Canada |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | USA |
 |
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | USA |
 |
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | USA |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.32 | 0.11 % | $ 352 M | Nasdaq Global Select Market | USA |
 |
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | USA |
 |
Orchard Therapeutics plc
ORTX
|
- | 1.02 % | $ 90.8 M | Nasdaq Global Select Market |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
- | - | $ 154 M | Nasdaq Capital Market | USA |
 |
Axsome Therapeutics
AXSM
|
$ 157.14 | 0.08 % | $ 7.82 B | Nasdaq Global Market,SPB | USA |
|
Oyster Point Pharma
OYST
|
- | - | $ 300 M | Nasdaq Global Select Market | USA |
 |
Intercept Pharmaceuticals
ICPT
|
- | - | $ 643 M | Nasdaq Global Select Market,SPB | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 4.07 | 0.97 % | $ 169 M | Nasdaq Global Select Market | Israel |
 |
9 Meters Biopharma
NMTR
|
- | -42.97 % | $ 1.05 M | Nasdaq Global Select Market | USA |
 |
Fortress Biotech
FBIO
|
$ 1.87 | 0.53 % | $ 52.2 M | Nasdaq Capital Market | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.15 | 3.2 % | $ 280 M | Nasdaq Global Select Market | USA |
 |
Otonomy
OTIC
|
- | -1.96 % | $ 4.68 M | Nasdaq Global Select Market | USA |
 |
Chinook Therapeutics
KDNY
|
- | - | $ 2.6 B | Nasdaq Global Select Market | USA |
|
Foghorn Therapeutics
FHTX
|
$ 1.85 | 2.16 % | $ 117 M | Nasdaq Global Market | USA |
 |
Galectin Therapeutics
GALT
|
$ 3.62 | 0.27 % | $ 231 M | Nasdaq Global Select Market | USA |
 |
BioCardia
BCDA
|
$ 0.92 | 0.01 % | $ 6.13 M | Nasdaq Global Select Market | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 7.79 | 0.19 % | $ 1.64 B | Nasdaq Global Select Market | USA |
 |
Puma Biotechnology
PBYI
|
$ 9.83 | 3.14 % | $ 492 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 63.62 | 0.67 % | $ 8.66 B | Nasdaq Global Select Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.01 | 8.87 % | $ 4.96 B | Nasdaq Capital Market | Israel |
 |
Pharming Group N.V.
PHAR
|
$ 9.36 | 0.42 % | $ 6.45 B | Nasdaq Global Select Market | Niderland |
|
Phathom Pharmaceuticals
PHAT
|
$ 6.92 | 1.35 % | $ 505 M | Nasdaq Global Select Market,SPB | USA |
 |
Pliant Therapeutics
PLRX
|
$ 0.9 | 10.01 % | $ 55.2 M | Nasdaq Global Select Market | USA |
 |
Equillium
EQ
|
$ 1.19 | 0.38 % | $ 68.2 M | Nasdaq Global Market | USA |
 |
GeoVax Labs
GOVX
|
$ 0.24 | 6.84 % | $ 230 K | Nasdaq Global Select Market | USA |
 |
PainReform Ltd.
PRFX
|
$ 0.78 | 3.32 % | $ 505 K | Nasdaq Capital Market | Israel |
 |
Theravance Biopharma
TBPH
|
$ 17.03 | 0.03 % | $ 857 M | Nasdaq Global Select Market |  Cayman-islands |
 |
Prothena Corporation plc
PRTA
|
$ 8.35 | 1.18 % | $ 449 M | Nasdaq Global Select Market,SPB | USA |